Print page Resize text Change font-size Change font-size Change font-size High contrast


       

 

 

 

About ENCePP

Find out more about the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance.

 

Are you a company seeking to commission or collaborate in the conduct of a post-authorisation study (PAS)?

Find out more

Do you wish to register a study in the EU PAS Register?

Find out more

Are you considering applying for an ENCePP study seal?

Read a personal account of the ENCePP study approval process

Are you interested in the recommendations from the European Medicines Agency's Pharmacovigilance Risk Assessment Committee (PRAC) on safety signals?

Review the list of signals discussed

 

 

 

Latest News
12 January 2018
ENCePP: 10 year anniversary article published online

An article reviewing ENCePP’s main achievements over the past ten years, discussing its impact on the benefit-risk evaluation of medicinal products in Europe and outlining future perspectives has been published online in Pharmacoepidemiology and Drug Safety (open access).

 

Related information:

» Strengthening standards, transparency, and collaboration to support medicine evaluation: Ten years of the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP)

9 January 2018
ENCePP activity report 2017

The ENCePP Secretariat has published a summary of the network's activities in 2017. The report provides a list of key achievements, a number of metrics relating to the network's expertise and experience, plus some website statistics.

 

Related information:

» ENCePP activity report 2017

3 January 2018
2018 ICPE abstract submission

Abstracts for the 34th International Conference on Pharmacoepidemiology and Therapeutic Risk Management (2018 ICPE) are now being accepted online. Deadline for submission is 14 February 2018.

 

Related information:

» 2018 ICPE - Submission of abstracts

 

More news ...